المؤلفون: Moustapha El-Amine, Kaity Posada, John L. Stauffer, Tracy Luckhardt, Renu Gupta, Ahmet Tutuncu, Eduard Gorina, Fernando J. Martinez, Robert J. Kaner, Majd Mouded, Ednan K Bajwa, Luca Richeldi, Howard M. Lazarus

المصدر: American journal of respiratory and critical care medicine. 200(2)

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, medicine.medical_specialty, Indoles, Pyridones, Vital Capacity, Anti-Inflammatory Agents, MEDLINE, Walk Test, Settore MED/10 - MALATTIE DELL'APPARATO RESPIRATORIO, Critical Care and Intensive Care Medicine, 03 medical and health sciences, chemistry.chemical_compound, Idiopathic pulmonary fibrosis, Anti-Inflammatory Agents, Non-Steroidal, Drug Approval, Drug Development, Drug Interactions, Drug Therapy, Combination, Humans, Idiopathic Pulmonary Fibrosis, Patient Outcome Assessment, Protein Kinase Inhibitors, Quality of Life, Standard of Care, Clinical Trials as Topic, 0302 clinical medicine, Quality of life (healthcare), Pharmacotherapy, Drug Therapy, medicine, 030212 general & internal medicine, Intensive care medicine, business.industry, Pirfenidone, medicine.disease, Clinical trial, 030228 respiratory system, Drug development, chemistry, Combination, Nintedanib, Non-Steroidal, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7887166b23e021466b4b10502c1bbf4e
https://pubmed.ncbi.nlm.nih.gov/30985215